LianBio (LIANY)
OTCMKTS: LIANY · Delayed Price · USD
0.311
-0.009 (-2.66%)
Jul 22, 2024, 9:53 AM EDT - Market open
LianBio Employees
LianBio had 163 employees as of December 31, 2022. The number of employees increased by 56 or 52.34% compared to the previous year.
Employees
163
Change (1Y)
56
Growth (1Y)
52.34%
Revenue / Employee
n/a
Profits / Employee
-$539,761
Market Cap
33.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 163 | 56 | 52.34% |
| Dec 31, 2021 | 107 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
LIANY News
- 5 months ago - LianBio Announces Voluntarily Delisting from Nasdaq - GlobeNewsWire
- 5 months ago - LianBio Announces Completion of Strategic Review - GlobeNewsWire
- 7 months ago - LianBio Announces Departure of Chief Financial Officer - GlobeNewsWire
- 7 months ago - LianBio Announces Departure of Chief Executive Officer - GlobeNewsWire
- 8 months ago - LianBio's Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciences - GlobeNewsWire
- 8 months ago - LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences - GlobeNewsWire
- 8 months ago - LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis - GlobeNewsWire